BiotechTube
Home/NurExone Biologic/Eyal Gabbai
EG

Eyal Gabbai

Director

NurExone Biologic

Therapeutic Areas

Central Nervous SystemOphthalmology

NurExone Biologic Pipeline

DrugIndicationPhase
ExoPTENAcute Spinal Cord InjuryPreclinical
ExoPTEN‑GlaucomaAcute GlaucomaPreclinical

Leadership Team at NurExone Biologic

LS
Lior Shaltiel, PhD
Chief Executive Officer & Director
EO
Eran Ovadya, MBA
Chief Financial Officer
TK
Tali Kizhner, PhD
R&D Director
IS
Ina Sarel, PhD
Head of CMC, Quality and Regulation
RP
Ram Petter, PhD, MBA
Head of Operations
YD
Yoram Drucker
Co‑Founder, Chairman & VP Strategic Development
View full NurExone Biologic profile